Co-existence of blaOXA-23 and armA in multidrugresistant Acinetobacter baumannii isolated from a hospital in South Korea

Journal of Medical Microbiology

Volumn 62, Issue PART6, 2013, Pages 836-844

  Hong, Seung Bok ^a   Shin, Kyeong Seob ^b   Ha, Jungsu ^c   Han, Kyudong ^c  

^a Chungbuk Health and Science University   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

^c Dankook University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEMASE; CIPROFLOXACIN; GENTAMICIN; HABEKACIN; IMIPENEM; METHYLTRANSFERASE; RNA 16S; TOBRAMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; RRNA (ADENOSINE O 2' )METHYLTRANSFERASE; RRNA (ADENOSINE-O-2'-)METHYLTRANSFERASE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE AMPLIFICATION; HOSPITAL; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTH KOREA; ACINETOBACTER INFECTION; CROSS INFECTION; DNA SEQUENCE; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; MULTIDRUG RESISTANCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; POLYMERASE CHAIN REACTION; REPUBLIC OF KOREA; SEQUENCE ANALYSIS, DNA;

MLCS; MLOWN;

EID: 84877852574     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.055384-0     Document Type: Article

References (47)

1. Apisarnthanarak, A. & Mundy, L. M. (2009). Mortality associated with Pandrug-resistant Acinetobacter baumannii infections in Thailand. Am J Infect Control 37, 519-520.
2. Bandelt, H. J., Forster, P. & Röhl, A. (1999). Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol 16, 37-48.
3. Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A., Wisplinghoff, H. & Rodríguez-Valera, F. (2005). Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43, 4382-4390.
4. Bogaerts, P., Galimand, M., Bauraing, C., Deplano, A., Vanhoof, R., De Mendonca, R., Rodriguez-Villalobos, H., Struelens, M. & Glupczynski, Y. (2007). Emergence of ArmA and RmtB aminoglycoside resistance 16S rRNA methylases in Belgium. J Antimicrob Chemother 59, 459-464.
5. Brigante, G., Migliavacca, R., Bramati, S., Motta, E., Nucleo, E., Manenti, M., Migliorino, G., Pagani, L., Luzzaro, F. & Viganò, F.E. (2012). Emergence and spread of a multidrug-resistant Acinetobacter baumannii clone producing both the carbapenemase OXA-23 and the 16S rRNA methylase ArmA. J Med Microbiol 61, 653-661.
6. CLSI (2012). Performance Standards for Antimicrobial Disk Diffusion Susceptibility Tests; 22nd Informational Supplement, Approved Standard M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute.
7. Deccache, Y., Irenge, L. M., Savov, E., Ariciuc, M., Macovei, A., Trifonova, A., Gergova, I., Ambroise, J., Vanhoof, R. & Gala, J. L. (2011). Development of a pyrosequencing assay for rapid assessment of quinolone resistance in Acinetobacter baumannii isolates. J Microbiol Methods 86, 115-118.
8. Diancourt, L., Passet, V., Nemec, A., Dijkshoorn, L. & Brisse, S. (2010). The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS ONE 5, e10034.
9. Doi, Y. & Arakawa, Y. (2007). 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 45, 88-94.
10. Doi, Y., Yokoyama, K., Yamane, K., Wachino, J., Shibata, N., Yagi, T., Shibayama, K., Kato, H. & Arakawa, Y. (2004). Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides. Antimicrob Agents Chemother 48, 491-496.
11. Doi, Y., de Oliveira Garcia, D., Adams, J. & Paterson, D. L. (2007). Coproduction of novel 16S rRNA methylase RmtD and metallo-βlactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil. Antimicrob Agents Chemother 51, 852-856.
12. Feil, E. J., Li, B. C., Aanensen, D. M., Hanage, W. P. & Spratt, B. G. (2004). eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 186, 1518-1530.
13. Galimand, M., Courvalin, P. & Lambert, T. (2003). Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob Agents Chemother 47, 2565-2571.
14. Gerner-Smidt, P. & Tjernberg, I. (1993). Acinetobacter in Denmark: II. Molecular studies of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. APMIS 101, 826-832.
15. Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41, 95-98.
16. Higgins, P. G., Dammhayn, C., Hackel, M. & Seifert, H. (2010). Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 65, 233-238.
17. Jeon, B.-C., Jeong, S. H., Bae, I. K., Kwon, S. B., Lee, K., Young, D., Lee, J. H., Song, J. S. & Lee, S. H. (2005). Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J Clin Microbiol 43, 2241-2245.
18. Jeong, H. W., Son, B. R., Shin, D. I., Ryu, D., Hong, S. B., Han, K. & Shin, K. S. (2011). Characterization of Acinetobacter baumannii coproducing carbapenemases OXA-23 and OXA-66, and armA 16S ribosomal RNA methylase at a university hospital in South Korea. Korean J Clin Microbiol 14, 67-73.
19. Jeong, S. H., Bae, I. K., Park, K. O., An, Y. J., Sohn, S. G., Jang, S. J., Sung, K. H., Yang, K. S., Lee, K. & other authors (2006). Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J Microbiol 44, 423-431.
20. Karah, N., Sundsfjord, A., Towner, K. & Samuelsen, O. (2012). Insights into the global molecular epidemiology of carbapenem nonsusceptible clones of Acinetobacter baumannii. Drug Resist Updat 15, 237-247.
21. Kim, C.-K., Lee, Y., Lee, H., Woo, G.-J., Song, W., Kim, M.-N., Lee, W.-G., Jeong, S. H., Lee, K. & Chong, Y. (2010). Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. Diagn Microbiol Infect Dis 68, 432-438.
22. PER-1 and armA in a Korean hospital. Clin Microbiol Infect 14, 716-718.
23. Lee, H., Yong, D., Yum, J. H., Roh, K. H., Lee, K., Yamane, K., Arakawa, Y. & Chong, Y. (2006). Dissemination of 16S rRNA methylase-mediated highly amikacin-resistant isolates of Klebsiella pneumoniae and Acinetobacter baumannii in Korea. Diagn Microbiol Infect Dis 56, 305-312.
24. Lee, K., Lim, Y. S., Yong, D., Yum, J. H. & Chong, Y. (2003). Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 41, 4623-4629.
25. Lee, K., Kim, M.-N., Choi, T. Y., Cho, S.-E., Lee, S., Whang, D. H., Yong, D., Chong, Y., Woodford, N., Livermore, D. M. & KONSAR Group (2009). Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea. Int J Antimicrob Agents 33, 520-524.
26. Lee, K., Kim, M.-N., Kim, J.-S., Hong, H. L., Kang, J. O., Shin, J.-H., Park, Y.-J., Yong, D., Jeong, S. H., Chong, Y. & KONSAR Group (2011). Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009. Yonsei Med J 52, 793-802.
27. Liu, Y.-H., Kuo, S.-C., Lee, Y.-T., Chang, I. C., Yang, S.-P., Chen, T.-L. & Fung, C.-P. (2012). Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU. J Microbiol Immunol Infect 45, 108-112.
28. OXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 16, 35-40.
29. Munoz-Price, L. S. & Weinstein, R. A. (2008). Acinetobacter infection. N Engl J Med 358, 1271-1281.
30. Park, Y. K., Choi, J. Y., Jung, S.-I., Park, K.-H., Lee, H., Jung, D. S., Heo, S. T., Kim, S.-W., Chang, H.-H. & other authors (2009). Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals. Diagn Microbiol Infect Dis 64, 389-395.
31. Peleg, A. Y., Seifert, H. & Paterson, D. L. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21, 538-582.
32. Ruiz, J. (2003). Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51, 1109-1117.
33. ABA-1 customized for Acinetobacter? FEMS Microbiol Lett 243, 425-429.
34. Sheng, W.-H., Lin, Y.-C., Wang, J.-T., Chen, Y.-C., Chang, S.-C., Hsia, K.-C., Wu, R.-J. & Li, S.-Y. (2009). Identification of distinct ciprofloxacin susceptibility in Acinetobacter spp. by detection of the gyrA gene mutation using real-time PCR. Mol Cell Probes 23, 154-156.
35. Stietz, M. S., Ramírez, M. S., Vilacoba, E., Merkier, A. K., Limansky, A. S., Centrón, D. & Catalano, M. (2013). Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III. Infect Genet Evol 14, 294-301.
36. Sung, J. Y., Kwon, K. C., Cho, H. H. & Koo, S. H. (2011). Antimicrobial resistance determinants in imipenem-nonsusceptible Acinetobacter calcoaceticus-baumannii complex isolated in Daejeon, Korea. Korean J Lab Med 31, 265-270.
37. OXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 44, 2974-2976.
38. Valenzuela, J. K., Thomas, L., Partridge, S. R., van der Reijden, T., Dijkshoorn, L. & Iredell, J. (2007). Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J Clin Microbiol 45, 453-460.
39. Vila, J., Ruiz, J., Goñi, P., Marcos, A. & Jimenez de Anta, T. (1995). Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 39, 1201-1203.
40. Villegas, M. V. & Hartstein, A. I. (2003). Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 24, 284-295.
41. Weisburg, W. G., Barns, S. M., Pelletier, D. A. & Lane, D. J. (1991). 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 173, 697-703.
42. Wilks, M., Wilson, A., Warwick, S., Price, E., Kennedy, D., Ely, A. & Millar, M. R. (2006). Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation. Infect Control Hosp Epidemiol 27, 654-658.
43. Woodford, N., Ellington, M. J., Coelho, J. M., Turton, J. F., Ward, M. E., Brown, S., Amyes, S. G. & Livermore, D. M. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27, 351-353.
44. Yan, J.-J., Wu, J.-J., Ko, W.-C., Tsai, S.-H., Chuang, C.-L., Wu, H.-M., Lu, Y.-J. & Li, J.-D. (2004). Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals. J Antimicrob Chemother 54, 1007-1012.
45. Yokoyama, K., Doi, Y., Yamane, K., Kurokawa, H., Shibata, N., Shibayama, K., Yagi, T., Kato, H. & Arakawa, Y. (2003). Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet 362, 1888-1893.
46. OXA-23 with armA and novel gyrA mutation in a pandrug-resistant Acinetobacter baumannii isolate from the blood of a patient with haematological disease in China. J Hosp Infect 77, 278-279.
47. Zong, Z., Lü, X., Valenzuela, J. K., Partridge, S. R. & Iredell, J. (2008). An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China. Int J Antimicrob Agents 31, 50-54.